Establishment Labs Holdings (ESTA) Return on Capital Employed (2018 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Return on Capital Employed came in at 10.55% in Q1 2026, up 1089.0% year-on-year from 0.89% in Q1 2025, and up 28.12% quarter-over-quarter from 14.67% in Q4 2025.
Establishment Labs Holdings (ESTA) Return on Capital Employed (2018 - 2026) Analysis & Trends
Establishment Labs Holdings' Return on Capital Employed history runs 9 years deep, the most recent figure standing at 10.55% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 1089.0% year-over-year to 10.55% in Q1 2026; TTM through Mar 2026 was 10.55%, a 1089.0% increase from a year earlier, with the FY2025 full-year figure at 14.46%, up 642.0% from the prior year.
- Return on Capital Employed grew to 10.55% in Q1 2026 per ESTA's latest filing, from 14.67% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 10.55% in Q1 2026 and bottomed at 30.61% in Q4 2023.
- The 5-year median for Return on Capital Employed is 24.38% (2024), against an average of 22.93%.
- Across the five-year window, Return on Capital Employed slumped 1142 bps in 2022 and jumped 1089 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 24.72% in 2022, then decreased by 24 bps to 30.61% in 2023, then surged by 34 bps to 20.28% in 2024, then increased by 28 bps to 14.67% in 2025, then climbed by 28 bps to 10.55% in 2026.
- Per Business Quant, the three latest ESTA Return on Capital Employed figures stand at 10.55% (Q1 2026), 14.67% (Q4 2025), and 20.49% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | -10.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.55% |
| Dec 31, 2025 | -14.67% |
| Sep 30, 2025 | -20.49% |
| Jun 30, 2025 | -25.07% |
| Mar 31, 2025 | -21.43% |
| Dec 31, 2024 | -20.28% |
| Sep 30, 2024 | -22.89% |
| Jun 30, 2024 | -24.38% |
| Mar 31, 2024 | -27.70% |
| Dec 31, 2023 | -30.61% |
| Sep 30, 2023 | -24.63% |
| Jun 30, 2023 | -22.32% |
| Mar 31, 2023 | -25.03% |
| Dec 31, 2022 | -24.72% |
| Sep 30, 2022 | -22.22% |
| Jun 30, 2022 | -25.29% |
| Mar 31, 2022 | -27.51% |
| Dec 31, 2021 | -22.44% |
| Sep 30, 2021 | -19.86% |
| Jun 30, 2021 | -13.87% |